Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03991169 · ClinicalTrials.gov registry record · Phase 4
Oral Iron in Children With Chronic Kidney Disease
A Phase 4 study of Chronic Kidney Diseases and Chronic Kidney Insufficiency, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT03991169: Recruiting Phase 4 study of Chronic Kidney Diseases and Chronic Kidney Insufficiency, sponsored by Weill Medical College of Cornell University.
NCT03991169 is a Phase 4 study of Chronic Kidney Diseases and Chronic Kidney Insufficiency that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 40 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03991169, a Phase 4 study of Chronic Kidney Diseases and Chronic Kidney Insufficiency, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a pilot clinical trial of oral iron therapy in children with chronic kidney disease (CKD) and mild anemia. Eligible children will be randomized into a standard of care (iron sulfate) arm vs. no iron therapy arm for 3 months. The outcomes will include muscle strength, physical activity, and changes in eating behavior, which will be measured at enrollment and at the end of the study period.
Primary Outcome
Hand-grip strength measured by a dynamometer
Conditions Studied
Interventions
- DRUG Ferrous Sulfate
Study Locations (2)
New York
- Weill Cornell Medicine / New York Presbyterian Hospital - New York
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-04-19 |
| Est. Completion | 2028-12-31 |
| Phase | Phase 4 |
What NCT03991169 shows while recruiting
NCT03991169 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Ferrous Sulfate is the first listed.
NCT03991169 reports a single indexed study location in New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03991169 about?
NCT03991169 is a clinical study titled "Oral Iron in Children With Chronic Kidney Disease". This is a pilot clinical trial of oral iron therapy in children with chronic kidney disease (CKD) and mild anemia. Eligible children will be randomized into a standard of care (iron sulfate) arm vs. no iron therapy arm for 3 months. The outcomes will include muscle strength, physical activity, and c...
What is the current status of trial NCT03991169?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2019-04-19. Estimated completion is 2028-12-31.
What conditions does trial NCT03991169 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Chronic Kidney Insufficiency.
What interventions are being tested in trial NCT03991169?
The interventions under investigation include: Ferrous Sulfate (DRUG).
Who is sponsoring clinical trial NCT03991169?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03991169 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03991169's enrollment target sits among peer trials
40 56th of 73 higher than 16 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
RECRUITING · Phase 4
-
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
RECRUITING · Phase 4
-
Ferric Citrate in ESRD Pilot Project
ACTIVE NOT RECRUITING · Phase 4
-
Immunogenicity of HPV Vaccine in Transplant Recipients.
ACTIVE NOT RECRUITING · Phase 4
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI